Robust sales in key markets boost Dr. Reddy’s Q1 net 18%
Pharma major Dr. Reddy’s Laboratories’ consolidated net profit rose more than 18% year-on-year for the quarter ended June to ₹1,405 crore, primarily on the back of higher sales in key markets for its generics, particularly North America, as…